What's New

  • 22 Oct 2020
    Antares Pharma to Report Third Quarter 2020 Finanical and Operating Results Read More

  • 01 Oct 2020
    Antares Pharma Enters Exclusive License Agreement with Ferring Pharmaceuticals For Nocdurna® In U.S. Read More

  • 08 Sep 2020
    Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Read More

$2.9100
$-0.0600
-2.0202%
Quotes delayed at least 15 minutes